Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study

Background: The COPCOV study (chloroquine/ hydroxychloroquine prevention of coronavirus disease), which started recruitment in April 2020, is a multi-country double-blind, randomised, placebo-controlled trial which is being conducted in healthcare facilities involved in COVID-19 case management. Par...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrone, Carlo, Schilling, William, Callery, James J., Ashley, Elizabeth A., Chambers, Mary, Chase, Hannah, Dahal, Piyush, Kanthawang, Nipaphan, Nedsuwan, Supalert, Hanboonkunupakarn, Borimas, Intralawan, Daranee, Karkey, Abhilasha, Mayxay, Mayfong, Souvong, Vimalay, Tran Minh, Hien, Udas Shakya, Summita, Sharma, Sanjib Kumar, Uranw, Surendra, Vannachione, Souphaphone, Woodrow, Charles, White, Nicholas J., Cheah, Phaik Yeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971639/
https://www.ncbi.nlm.nih.gov/pubmed/36866279
http://dx.doi.org/10.12688/wellcomeopenres.16880.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971639/
https://www.ncbi.nlm.nih.gov/pubmed/36866279
http://dx.doi.org/10.12688/wellcomeopenres.16880.3

Ejemplares similares